Thyrocare Technologies Limited — Important, 13-08-2026: Updates
13-08-2026 | 10:56 am
13-08-2026 | 10:56 am
Thyrocare's promoter, Docon Technologies, sold 1.58 Cr shares, reducing its stake from 60.92% to 51.02%. This represents 9.90% of total equity. Docon remains a promoter.
No comments yet. Be the first to comment!
